These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22498014)

  • 1. Hemostatic abnormalities and relationships to metabolic and hormonal status in polycystic ovarian syndrome.
    Burchall G; Linden MD; Teede H; Piva TJ
    Trends Cardiovasc Med; 2011 Jan; 21(1):6-14. PubMed ID: 22498014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L; Teede H
    Hum Reprod Update; 2009; 15(4):477-88. PubMed ID: 19279045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome and the metabolic syndrome.
    Weerakiet S
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.
    Diamanti-Kandarakis E
    Expert Rev Mol Med; 2008 Jan; 10():e3. PubMed ID: 18230193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovarian syndrome in adolescence.
    Yii MF; Lim CE; Luo X; Wong WS; Cheng NC; Zhan X
    Gynecol Endocrinol; 2009 Oct; 25(10):634-9. PubMed ID: 19533479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polycystic ovary syndrome (PCOS)].
    Torre A; Fernandez H
    J Gynecol Obstet Biol Reprod (Paris); 2007 Sep; 36(5):423-46. PubMed ID: 17540511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.
    Pasquali R; Gambineri A
    Ann N Y Acad Sci; 2006 Dec; 1092():158-74. PubMed ID: 17308142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF
    Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovarian syndrome.
    Trikudanathan S
    Med Clin North Am; 2015 Jan; 99(1):221-35. PubMed ID: 25456652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.
    Talbott EO; Zborowskii JV; Boudraux MY
    Minerva Ginecol; 2004 Feb; 56(1):27-39. PubMed ID: 14973408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women.
    Alexander CJ; Tangchitnob EP; Lepor NE
    Rev Cardiovasc Med; 2009; 10(2):83-90. PubMed ID: 19593320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome.
    Diamanti-Kandarakis E; Christakou C; Kandarakis H
    Minerva Endocrinol; 2007 Mar; 32(1):35-47. PubMed ID: 17353865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens in polycystic ovary syndrome: the role of exercise and diet.
    Giallauria F; Palomba S; Vigorito C; Tafuri MG; Colao A; Lombardi G; Orio F
    Semin Reprod Med; 2009 Jul; 27(4):306-15. PubMed ID: 19530064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.